Online Trial Tracker - Larvol Sigma

Welcome, Profile Billing Logout

1 Trials

All TrialsPhase N/A

Trial + Data / Events

Status

Region

Interventions

Sponsor

Conditions

Primary compl

Study compl

Rapivab (peramivir) / BioCryst

NCT01146353: Pharmacokinetic Assessment of Peramivir in Hospitalized Adults Undergoing Continuous Renal Replacement Therapy

Withdrawn

N/A

Midwestern University, Northwestern University, BioCryst Pharmaceuticals

Influenza, Renal Failure

02/11

Download Options



	Diseases Companies Products Productz Mechanisms of Action Sites